ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 755417 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 755417; 2) Community: the network communities that were significantly associated with the response to NSC 755417; 3) Molecule: the relationships between components within communities and NSC 755417; 4) MDR: the compounds that were significantly associated with the NSC 755417.

NSC Compound Enrichment Correlation
NSC 93674 Oxyacanthan-7,12'-diol, 6,6'-dimethoxy-2,2'-dimethyl- 0.00163653239752571 0.42952486
NSC 173552 L-Aspartic acid, N-[4-[[(2-amino-4-hydroxy-6-quinazolinyl)methyl]amino]benzoyl]-, monohydrate 0.00163653239752573 0.59422108
NSC 300289 Pinafide 0.00163653239752573 0.42562674
NSC 303861 L-Cysteine analog 0.00163653239752573 0.53570888
NSC 30722 Pyrimidine, 2,4,6-trichloro-5-methyl- 0.00163653239752573 0.25838239
NSC 33570 Null 0.00163653239752573 0.26017429
NSC 339579 7H-Pyrrolo[3,2-f]quinazoline-2,4-diamine, 7-[(3-nitrophenyl)methyl]-, monoacetate 0.00163653239752573 0.57265614
NSC 363813 Platinum, tetrachloro(1,2-cyclohexanediamine-N,N')-, [OC-6-22-(1S-trans)]- 0.00163653239752573 0.32025567
NSC 372155 2-Propenamide, N-[(cyanoamino)iminomethyl]-2-methyl- 0.00163653239752573 0.087617648
NSC 40618 Cyclohexanone, 2,6-dibenzylidene- (8CI) 0.00163653239752573 0.50987209
Total:198  Current:21    [First] [Prev] [Next] [Last]